Literature DB >> 325715

Antigen-reactive cell opsonization (ARCO): a mechanism of immunological enhancement.

I V Hutchinson, H Zola.   

Abstract

Rat renal allograft survival is markedly prolonged by passive enhancement. Radio-labelled AS-anti-HO antigen-reactive cells (*ARC) were prepared by immunizing AS rats with HO rat tissue and injecting 125IUdR over a period of 4 days. Most of the radioactivity in spleen cells from these rats were associated with antigen-reactive cells which formed rosettes specifically with HO erythrocytes. *ARC were specifically opsonized in syngeneic AS rats bearing enhanced (AS times HO)F1 kidney allografts but not in untreated, rejecting allografted rats. *ARC incubated in vitro with serum from enhanced rats and injected into normal animals were opsonized whereas serum from rats rejecting grafts was ineffective. *ARC incubated in vitro with hyperimmune AS-anti-HO serum were not opsonized, unless the antiserum was first incubated with HO tissue under conditions favouring the formation of immune complexes. These results are consistent with the hypothesis that ARC bind antigenic determinants of antigen-antibody complexes and are opsonized by virtue of the antibody Fc portion of the complexes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325715     DOI: 10.1097/00007890-197706000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats.

Authors:  N Murase; D G Kim; S Todo; D V Cramer; J Fung; T E Starzl
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

2.  Mechanisms of transplantation tolerance induced by liver grafting in rats: involvement of serum factors in clonal deletion.

Authors:  N Kamada; R Sumimoto; A Baguerizo; A Yoshimatsu; K Teramoto; A Yamaguchi
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

3.  Opsonization of tumor-reactive T cells in SJL/J mice bearing syngeneic tumors.

Authors:  I V Hutchinson; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.